SFRP1 and lung cancer: Dysregulation of canonical Wnt signaling has also been demonstrated in lung cancer, mediated through epigenetic silencing of negative regulators such as SFRP1 and WIF-1[34], [35] or rare mutations in APC and β-catenin [36], [37].